| Literature DB >> 36061852 |
Suk-Yong Jang1, Yonghan Cha2, Kap-Jung Kim2, Ha-Yong Kim2, Won-Sik Choy3, Kyung-Hoi Koo2.
Abstract
Background: The aim of this study was to investigate the incidence rate of suicide deaths in elderly patients with pelvic fractures using a nationwide database and to analyze change in the risk of suicide death overtime after pelvic fractures compared to controls.Entities:
Keywords: Elderly; Pelvic fracture; Suicide death
Mesh:
Year: 2022 PMID: 36061852 PMCID: PMC9393277 DOI: 10.4055/cios21190
Source DB: PubMed Journal: Clin Orthop Surg ISSN: 2005-291X
Incidence Rates of Suicide Death in Elderly Patients with Pelvic Fractures
| Exposure | No. of patients | No. of suicide deaths | Person-years | Incidence rate (95% CI) per 100,000 person-years |
|---|---|---|---|---|
| 0–1 yr | 5,198 | 13 | 4,543.0 | 285.3 (165.6–491.4) |
| 1–2 yr | 4,053 | 4 | 3,658.2 | 109.0 (40.9–290.4) |
| 0–2 yr | 5,198 | 17 | 8,201.2 | 206.9 (128.6–333.0) |
| 2–3 yr | 3,296 | 1 | 2,934.7 | 34.0 (4.8–241.2) |
| 0–3 yr | 5,198 | 18 | 11,135.9 | 161.43 (101.7–256.3) |
| Whole period | 5,198 | 26 | 20,279.8 | 128.1 (87.2–188.3) |
CI: confidence interval.
Baseline Characteristics of the Sample
| Characteristic | Suicide case (n = 2,863) | Control (n = 14,315) | Crude OR (95% CI) | ||
|---|---|---|---|---|---|
| Age (yr) | 76.75 ± 6.89 | 76.75 ± 6.89 | Matched | ||
| 65–69 | 453 (15.82) | 2,265 (15.82) | |||
| 70–74 | 759 (26.51) | 3,795 (26.51) | |||
| 75–79 | 710 (24.80) | 3,550 (24.80) | |||
| 80–84 | 524 (18.30) | 2,620 (18.30) | |||
| ≥ 85 | 417 (14.57) | 2,085 (14.57) | |||
| Sex | Matched | ||||
| Male | 986 (34.44) | 4,930 (34.44) | |||
| Female | 1,877 (65.56) | 9,385 (65.56) | |||
| Household income level | 0.92 (0.90–0.95) | ||||
| Low | 523 (18.27) | 2,317 (16.19) | |||
| Mid–low | 372 (12.99) | 1,646 (11.50) | |||
| Middle | 428 (14.95) | 1,869 (13.06) | |||
| Mid–high | 581 (20.29) | 2,696 (18.83) | |||
| High | 959 (33.50) | 5,787 (40.43) | |||
| Residential area | 1.22 (1.12–1.32) | ||||
| Metropolitan | 991 (34.61) | 5,596 (39.09) | |||
| Non-metropolitan | 1,872 (65.39) | 8,719 (60.91) | |||
| Registered disability | 47 (1.64) | 249 (1.74) | 0.94 (0.69–0.30) | ||
| Calendar year | Matched | ||||
| 2002–2005 | 609 (21.27) | 3,045 (21.27) | |||
| 2006–2009 | 667 (23.30) | 3,335 (23.30) | |||
| 2010–2012 | 798 (27.87) | 3,990 (27.87) | |||
| 2013–2015 | 789 (27.56) | 3,945 (27.56) | |||
| Charlson comorbidity index score | 1.11 (1.08–1.15) | ||||
| 0 | 1,200 (41.91) | 6,734 (47.04) | |||
| 1 | 784 (27.38) | 3,838 (26.81) | |||
| 2 | 430 (15.02) | 1,909 (13.34) | |||
| 3 | 225 (7.86) | 989 (6.91) | |||
| 4 | 95 (3.32) | 401 (2.80) | |||
| ≥ 5 | 129 (4.51) | 444 (3.10) | |||
| Past history of hospital admissions | 1,307 (45.65) | 6,535 (45.65) | Matched | ||
| No. of outpatient visits | 1.15 (1.11–1.19) | ||||
| 0 | 121 (4.23) | 729 (5.09) | |||
| 1–9 | 562 (19.63) | 3,018 (21.08) | |||
| 10–19 | 681 (23.79) | 3,865 (27.00) | |||
| 20–29 | 473 (16.52) | 2,629 (18.37) | |||
| ≥ 30 | 1,026 (35.84) | 4,074 (28.46) | |||
| Past medication history | |||||
| Anti-hypertensive agent | 1,805 (63.05) | 8,792 (61.42) | 1.08 (0.99–1.18) | ||
| Anti-diabetic agent | 572 (19.98) | 2,774 (19.38) | 1.04 (0.94–1.15) | ||
| Lipid lowering agent | 677 (23.65) | 3,849 (26.89) | 0.82 (0.74–0.91) | ||
| Steroid | 1,170 (40.87) | 5,044 (35.24) | 1.32 (1.21–1.45) | ||
| Benzodiazepine | 1,833 (64.02) | 7,609 (53.15) | 1.76 (1.61–1.93) | ||
| Opioid (prescription day) | 1.10 (1.06–1.14) | ||||
| 0 < day ≤ 14 | 602 (21.03) | 3,154 (22.03) | |||
| 15 < day ≤ 30 | 347 (12.12) | 2,035 (14.22) | |||
| 31 < day ≤ 60 | 371 (12.96) | 2,083 (14.55) | |||
| > 61 day | 1,257 (43.91) | 5,491 (38.36) | |||
| Anti-rheumatic agent | 36 (1.26) | 155 (1.08) | 1.17 (0.81–1.68) | ||
| Non-steroidal anti-inflammatory agent | 1,868 (65.25) | 8,924 (62.34) | 1.18 (1.07–1.29) | ||
| Cox-2 inhibitor | 249 (8.70) | 1252 (8.75) | 0.99 (0.86–1.15) | ||
| Anti-platelet | 1,253 (43.77) | 6,431 (44.92) | 0.95 (0.87–1.03) | ||
| Parkinson medication | 129 (4.51) | 516 (3.60) | 1.28 (1.04–1.57) | ||
| Alzheimer medication | 122 (4.26) | 896 (6.26) | 0.63 (0.52–0.78) | ||
| Aspirin | 1,121 (39.15) | 5,766 (40.28) | 0.95 (0.87–1.04) | ||
| Anti-epileptic drug | 273 (9.54) | 1,161 (8.11) | 1.21 (1.05–1.40) | ||
| Warfarin | 67 (2.34) | 369 (2.58) | 0.91 (0.70–1.18) | ||
| Anti-psychotic drug | 1,121 (39.15) | 5,766 (40.28) | 0.95 (0.87–1.04) | ||
| Past medical history | |||||
| Neoplasm | 238 (8.31) | 867 (6.06) | 1.44 (1.24–1.69) | ||
| Ischemic heart disease | 256 (8.94) | 1,374 (9.60) | 0.92 (0.80–1.06) | ||
| Stroke | 252 (8.80) | 1,088 (7.60) | 1.18 (1.02–1.37) | ||
| Chronic kidney disease | 43 (1.50) | 199 (1.39) | 1.08 (0.78–1.51) | ||
| Depression | Matched | ||||
| Diagnosis and medication | 11 (0.38) | 55 (0.38) | |||
| Medication only | 707 (24.69) | 3,535 (24.69) | |||
Values are presented as mean ± standard deviation or number (%) unless otherwise indicated.
OR: odds ratio, CI: confidence interval.
Increased Risk of Suicide in Elderly Patients after Pelvic Fractures
| Exposure | No. of pelvic fractures | Crude OR (95% CI) | Adjusted OR (95% CI) | |||
|---|---|---|---|---|---|---|
| Suicide case (n = 2,386) | Control (n = 14,315) | |||||
| Within 1 yr | 12 (0.42) | 23 (0.16) | 2.65 (1.31–5.37) | 0.007 | 2.65 (1.29–5.45) | 0.008 |
| Within 2 yr | 14 (0.49) | 27 (0.19) | 2.63 (1.37–5.04) | 0.004 | 2.59 (1.33–5.04) | 0.005 |
| Within 3 yr | 15 (0.52) | 36 (0.25) | 2.10 (1.15–3.85) | 0.017 | 2.13 (1.15–3.95) | 0.017 |
| Within 4 yr | 16 (0.56) | 45 (0.31) | 1.79 (1.01–3.17) | 0.047 | 1.77 (0.99–3.18) | 0.055 |
| Within 5 yr | 16 (0.56) | 51 (0.36) | 1.58 (0.90–2.77) | 0.114 | 1.52 (0.86–2.70) | 0.151 |
| Whole period | 22 (0.77) | 68 (0.48) | 1.63 (1.01–2.65) | 0.048 | 1.55 (0.95–2.54) | 0.082 |
Values are presented as number (%) unless otherwise indicated.
OR: odds ratio, CI: confidence interval.